Quantum-Si (QSI) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$1.6M

Revenue (quarter)

$344,000.00

Revenue growth (year over year)

−41.79%

Gross profit (trailing twelve months)

$562,000.00

Gross margin

35.02%

Net income (trailing twelve months)

−$98.5M

Net income (quarter)

−$23.5M

Net income growth (year over year)

+18.39%

Net margin

−6138.26%

Return on equity

−49.11%

EPS (trailing twelve months)

−$0.46

Book value per share

$0.82

P/E (trailing twelve months)

—

Price to book

1.60

Debt to assets

6.91%

Payout ratio

—

Dividend yield

—

Company profile

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

• Is Quantum-Si (QSI) profitable?

  No. Quantum-Si reported a net loss of $98.5M over the trailing twelve months.

• How much revenue does Quantum-Si (QSI) make?

  Quantum-Si generated $1.6M in revenue over the trailing twelve months, down 41.79% year over year.

• How do I buy stock in Quantum-Si (QSI)?

  QSI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.